Fosun Pharma launches dual stock incentive plans

Shanghai Fosun Pharmaceutical Group announced two new employee incentive schemes following board approval on August 22, 2025. The A-share stock option incentive plan totals 5,726,100 A-share options, while the H-share restricted share unit plan grants 13,370,500 H-share units.

The plans will be submitted for shareholder approval and target executive directors, employee directors, senior management, and core personnel. Executive directors Chen Yuqing and Guan Xiaohui abstained from voting due to their direct participation in the schemes.